Brief: Lexicon Pharmaceuticals Q4 EPS USD -0.04
05/03/2026 11:59
Mar 05 (Reuters) - Lexicon Pharmaceuticals Q4 operating income USD -14.78 million. Q4 product revenue USD 1.055 million Q4 basic EPS USD -0.04 Q4 net income USD -15.53 million Q4 operating expenses USD 20.273 million
Recent news on Lexicon Pharmaceuticals
See all newsLexicon Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Lexicon Pharmaceuticals posts Q2 net loss
Brief: Lexicon Pharmaceuticals Q2 EPS USD -0.07
Lexicon Pharmaceuticals Inc expected to post a loss of 5 cents a share - Earnings Preview
Lexicon Pharmaceuticals Inc expected to post a loss of 5 cents a share - Earnings Preview